Skip to main content

Advertisement

SpringerLink
Log in

Recent advances in pediatric liver transplantation

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Pediatric liver transplantation has matured into a wellestablished, highly successful treatment for advanced pediatric liver disease. Recent 1-year success rates range from 85% to 95%. This unprecedented achievement is the result of careful selection criteria and optimal timing of transplantation, technical advances in surgical technique, and improved treatment following transplant. This report highlights many recent published findings representing advances that have led to current successful approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Studies of pediatric liver transplantation (SPLIT): year 2000 outcomes. Transplantation 2001, 72:463–476. This is the first major multicenter database reported in the United States. It represents a tremendous collaborative effort and includes a great deal of benchmark information regarding pediatric liver transplantation.

    Article  Google Scholar 

  2. Shapiro R, Weismann I, Mandel H, et al.: Primary hyperoxaluria type 1: improved outcome with timely liver transplantation: a single-center report of 36 children. Transplantation 2001, 72:428–432. One of the largest single-center experiences with primary hyperoxaluria.

    Article  PubMed  CAS  Google Scholar 

  3. Saborio P, Scheinman J: Transplantation for primary hyperoxaluria in the United States. Kidney Int 1999, 56:1094–1100.

    Article  PubMed  CAS  Google Scholar 

  4. Cochat P, Gaulier J, Nogueira P, et al.: Combined liver-kidney transplantation in primary hyperoxaluria type 1. Eur J Pediatr 1999, 158(suppl 2):S75-S80.

    Article  PubMed  Google Scholar 

  5. Gruessner R: Preemptive liver transplantation from a living related donor for primary hyperoxaluria type 1 [letter]. N Engl J Med 1998, 338:1924. This innovative paper describes the first preemptive liver transplant for primary hyperoxaluria. This approach, when feasible, will potentially avoid the need for renal transplantation.

    Article  PubMed  CAS  Google Scholar 

  6. Nolkemper D, Kemper M, Burdelski M, et al.: Long-term results of pre-emptive liver transplantation in primary hyperoxaluria type 1. Pediatr Transplantation 2000, 4:177–181.

    Article  CAS  Google Scholar 

  7. van der Veere C, Sinaasappel M, McDonagh A, et al.: Current therapy for Crigler-Najjar syndrome type I: report of a world registry. Hepatology 1996, 24:311–315.

    Article  PubMed  Google Scholar 

  8. Jansen P: Diagnosis and management of Crigler-Najjar syndrome. Eur J Pediatr 1999, 158(suppl 2):S89-S94.

    Article  PubMed  Google Scholar 

  9. Kren B, Parashar B, Bandhopadhyaya B, et al.: Correction of UDP-glucuronyltransferase gene defect in Gunn rat model of Crigler-Najjar syndrome type I with a chimeric oligonucleotide. Proc Natl Acad Sci U S A 1999, 96:10349–10354. A fascinating molecular approach to correction of genetic defects. This elegant approach may be reality in the next 5 to 10 years, and should be kept in mind as therapeutic approaches are considered.

    Article  PubMed  CAS  Google Scholar 

  10. Saudubray J, Touati G, Delonlay P, et al.: Liver transplantation in urea cycle disorders. Eur J Pediatr 1999, 158(suppl 2):S55-S59.

    Article  PubMed  Google Scholar 

  11. Ban K, Sugiyama N, Sugiyama K, et al.: A pediatric patient with classical citrullinemia who underwent living-related partial liver transplantation. Transplantation 2001, 71:1495–1497.

    Article  PubMed  CAS  Google Scholar 

  12. Busuttil A, Goss J, Seu P, et al.: The role of orthotopic liver transplantation in the treatment of ornithine transcarbamylase deficiency. Liver Transpl Surg 1998, 4:350–354.

    Article  PubMed  CAS  Google Scholar 

  13. Croffie J, Gupta S, Chong S, Fitzgerald J: Tyrosinemia type 1 should be suspected in infants with severe coagulopathy even in the absence of other signs of liver failure. Pediatrics 1999, 103:675–678.

    Article  PubMed  CAS  Google Scholar 

  14. Lindstedt S, Holme E, Lock E: Treatment of hereditary tyrosinemia type 1 by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 1992, 340:813–817.

    Article  PubMed  CAS  Google Scholar 

  15. Holme E, Lindstedt S: Diagnosis and management of tyrosinemia type 1. Curr Opin Pediatr 1995, 7:716–723.

    Google Scholar 

  16. Mohan N, McKiernan P, Preece M, et al.: Indications and outcome of liver transplantation in tyrosinaemia type 1. Eur J Pediatr 1999, 158(suppl 2):S49-S54.

    Article  PubMed  Google Scholar 

  17. Sokal E, Sokol R, Cormier V, et al.: Liver transplantation in mitochondrial respiratory chain disorders. Eur J Pediatr 1999, 158(suppl 2):S81-S84.

    Article  PubMed  Google Scholar 

  18. Thomson M, McKiernan P, Buckels J, et al.: Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplantation in childhood. J Pediatr Gastroenterol Nutr 1998, 26:478–481. An important caution for all pediatric liver transplant centers.

    Article  PubMed  CAS  Google Scholar 

  19. Romero R: The difficulty with rapid communication: fulminant hepatic failure in infancy. J Pediatr Gastroenterol Nutr 1998, 26:472–474.

    Article  PubMed  CAS  Google Scholar 

  20. Delarue A, Paut O, Guys J-M, et al.: Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure. Pediatr Transplantation 2000, 4:67–71.

    Article  CAS  Google Scholar 

  21. Thomson M, Lynch S, Strong R, et al.: Orthotopic liver transplantation with poor neurologic outcome in valproateassociated liver failure: a need for critical risk-benefit appraisal in the use of valproate. Transplant Proc 2000, 32:200–203.

    Article  PubMed  CAS  Google Scholar 

  22. Shneider BL: Genetic cholestasis syndromes. J Pediatr Gastroenterol Nutr 1999, 28:124–131.

    Article  PubMed  CAS  Google Scholar 

  23. Bull LN, van Eijk MJT, Pawlikowska L, et al.: Identification of a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998, 18:219–224.

    Article  PubMed  CAS  Google Scholar 

  24. Whitington PF, Freese DK, Alonso EM, et al.: Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994, 18:134–141.

    Article  PubMed  CAS  Google Scholar 

  25. Whitington PF, Whitington GL: Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology 1988, 95:130–136.

    PubMed  CAS  Google Scholar 

  26. Hollands CM, Rivera-Pedrogo J, Gonzalez-Vallina R, et al.: Ileal exclusion for Byler’s disease: an alternative surgical approach with promising early results for pruritus. J Pediatr Surg 1998, 33:220–224.

    Article  PubMed  CAS  Google Scholar 

  27. Ismail H, Kalicinski P, Markiewicz M, et al.: Treatment of progressive familial intrahepatic cholestasis: liver transplantation or partial external biliary diversion. Pediatr Transplantation 1999, 3:219–224. The clinical experience of a cohort of Polish children with progressive familial intrahepatic cholestasis is presented. The important role of partial external biliary diversion in avoiding liver transplantation is emphasized.

    Article  CAS  Google Scholar 

  28. Bull LN, Varlton VEH, Stricker NL, et al.: Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 1997, 26:155–164.

    Article  PubMed  CAS  Google Scholar 

  29. Davidson M, Dillon M, Gordon B, et al.: Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects. Arch Intern Med 1999, 159:1893–1900.

    Article  PubMed  CAS  Google Scholar 

  30. Higaki J, Hara S, Takasu N, et al.: Inhibition of ileal Na+/bile acid cotransporter by S-8921 reduces serum cholesterol and prevents atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1998, 18:1304–1311.

    PubMed  CAS  Google Scholar 

  31. Lewis MC, Brieaddy LE, Root C: Effect of 2164U90 on ileal bile acid absorption and serum cholesterol in rats and mice. J Lipid Res 1995, 36:1098–1105.

    PubMed  CAS  Google Scholar 

  32. Emerick K, Rand E, Goldmuntz E, et al.: Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology 1999, 29:822–829.

    Article  PubMed  CAS  Google Scholar 

  33. Gurkan A, Emre S, Fishbein T, et al.: Unsuspected bile duct paucity in donors for living-related liver transplantation: two case reports. Transplantation 1999, 67:416–418.

    Article  PubMed  CAS  Google Scholar 

  34. Daugherty C, Setchell K, Heubi J, Balistreri W: Resolution of liver biopsy alterations in three siblings with bile acid treatment of an inborn error of bile acid metabolism (delta4-3-oxosteroid 5beta-reductase deficiency). Hepatology 1993, 18:1096–1101.

    PubMed  CAS  Google Scholar 

  35. Ichimiya H, Nazer T, Gunasekaran T, et al.: Treatment of chronic liver disease caused by 3beta-hydroxy-delta5-C27-steroid dehydrogenase deficiency with chenodeoxycholic acid. Arch Dis Child 1990, 65:1121–1124.

    PubMed  CAS  Google Scholar 

  36. Setchell KDR, Schwarz M, O‘Connell NC, et al.: Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7delta-hydroxylase gene causes severe neonatal liver disease. J Clin Invest 1998, 102:1690–1703.

    Article  PubMed  CAS  Google Scholar 

  37. Emre S, Kitibayashi K, Schwartz M, et al.: Liver transplantation in a patient with acute liver failure due to sickle cell intrahepatic cholestasis. Transplantation 2000, 69:675–676.

    Article  PubMed  CAS  Google Scholar 

  38. Shneider BL: Neonatal liver failure. Curr Opin Pediatr 1996, 8:495–501.

    Article  PubMed  CAS  Google Scholar 

  39. Parizhskaya M, Reyes J, Jaffe R: Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis. Pediatr Develop Pathol 1999, 2:360–366.

    Article  CAS  Google Scholar 

  40. Hadzic N, Pritchard J, Webb D, et al.: Recurrence of langerhans cell histiocytosis in the graft after pediatric liver transplantation. Transplantation 2000, 70:815–819.

    Article  PubMed  CAS  Google Scholar 

  41. Laine J, Jalanko H, Saarinen-Pihkala U, et al.: Successful liver transplantation after induction chemotherapy in children with inoperable, multifocal primary hepatic malignancy. Transplantation 1999, 67:1369–1372.

    Article  PubMed  CAS  Google Scholar 

  42. Dower N, Smith L, Lees G, et al.: Experience with aggressive therapy in three children with unresectable malignant liver tumors. Med Pediatr Oncol 2000, 34:132–135.

    Article  PubMed  CAS  Google Scholar 

  43. Gerber D, Arcement C, Carr B, et al.: Use of intrahepatic chemotherapy to treat advanced pediatric hepatic malignancies. J Pediatr Gastroenterol Nutr 2000, 30:137–144.

    Article  PubMed  CAS  Google Scholar 

  44. Shneider B, Haque S, van Hoff J, et al.: Familial adenomatous polyposis following transplantation for a virilizing hepatoblastoma. J Pediatr Gastroenterol Nutr 1992, 15:198–201.

    Article  PubMed  CAS  Google Scholar 

  45. Miles F, Kamath R, Dorney S, et al.: Accidental paracetamol overdosing and fulminant hepatic failure. Med J Aust 1999, 171:472–475.

    PubMed  CAS  Google Scholar 

  46. Heubi J, Barbacci M, Zimmerman H: Therapeutic misdaventures with acetaminophen: hepatotoxicity after multiple doses in children. J Pediatr 1998, 132:22–27. This is an excellent review of a multitude of examples of unexpected acetaminophen-related hepatotoxicity.

    Article  PubMed  CAS  Google Scholar 

  47. Achilleos O, Mirza D, Talbot D, et al.: Outcome of liver retransplantation in children. Liver Transpl Surg 1999, 5:401–406.

    Article  PubMed  CAS  Google Scholar 

  48. Newell K, Millis J, Bruce D, et al.: An analysis of hepatic retransplantation in children. Transplantation 1998, 65:1172–1178.

    Article  PubMed  CAS  Google Scholar 

  49. Sieders E, Peeters P, TenVergert E, et al.: Retransplantation of the liver in children. Transplantation 2001, 71:90–95.

    Article  PubMed  CAS  Google Scholar 

  50. Vohra P, Haller C, Emre S, et al.: Neonatal hemochromatosis: the importance of early recognition of liver failure. J Pediatr 2000, 136:537–541.

    Article  PubMed  CAS  Google Scholar 

  51. de Boissieu D, Knisely A: Neonatal hemochromatosis. In Liver Disease in Children, edn 2. Edited by Suchy F, Sokol R, Balistreri W. Philadelphia: Lippincott; 2000:641–648.

    Google Scholar 

  52. Woodle E, Millis M, So S, et al.: Liver transplantation in the first three months of life. Transplantation 1998, 66:606–609. An excellent case series describing the course of liver transplantation in very young recipients.

    Article  PubMed  CAS  Google Scholar 

  53. Reichert P, Renz J, Rosenthal P, et al.: Biliary complications of reduced-organ liver transplantation. Liver Transpl Surg 1998, 4:343–349.

    Article  PubMed  CAS  Google Scholar 

  54. Otte J, de Ville de Goyet J, Reding R, et al.: Pediatric liver transplantation: from the full size liver graft to reduced, split and living related transplantation. Pediatr Surg Int 1998, 13:308–318.

    Article  PubMed  CAS  Google Scholar 

  55. Emond J, Whitington P, Thistlethwaite J, et al.: Reduced-sized orthotopic liver transplantation: use in the management of children with chronic liver disease. Hepatology 1989, 10:867–872.

    Article  PubMed  CAS  Google Scholar 

  56. de Santibanes E, McCormack L, Mattera J, et al.: Partial left lateral segment transplant from a living donor. Liver Transpl 2000, 6:108–112.

    Article  PubMed  Google Scholar 

  57. Srinivasan P, Vilca-Melendez H, Muiesan P, et al.: Liver transplantation with monosegments. Surgery 1999, 126:10–12. The use of monosegments for transplantation of infants is described. This represents an important advancement in management of the newborn with liver failure.

    Article  PubMed  CAS  Google Scholar 

  58. Pichlmayr R, Bretschneider H, Kirchner E, et al.: Ex situ operation on the liver: a new possibility in liver surgery. Langenbecks Arch Chir 1988, 373:122–126.

    Article  PubMed  CAS  Google Scholar 

  59. Otte J, de Ville de Goyet J, Alberti D, et al.: The concept and technique of the split liver in clinical transplantation. Surgery 1990, 107:605–612.

    PubMed  CAS  Google Scholar 

  60. Goss J, Yersiz H, Shackleton C, et al.: In situ splitting of the cadaveric liver for transplantation. Transplantation 1997, 64:871–877.

    Article  PubMed  CAS  Google Scholar 

  61. Katz E, Miller C, Nour B, et al.: The first in situ split of a liver in the USA performed by two geographically distant transplant centers-enhancing, sharing and expanding the cadaveric liver organ pool. J Okla State Med Assoc 1997, 90:442–443.

    PubMed  CAS  Google Scholar 

  62. Ghobrial R, Yersiz H, Farmer D, et al.: Predictors of survival after in vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg 2000, 232:312–323.

    Article  PubMed  CAS  Google Scholar 

  63. Chardot C, Branchereau S, de Dreuzy O, et al.: Paediatric liver transplantation with a split graft: experience at Bicetre. Eur J Pediatr Surg 1999, 9:146–152.

    PubMed  CAS  Google Scholar 

  64. Spada M, Gridelli B, Colledan M, et al.: Extensive use of split liver for pediatric liver transplantation: a single-center experience. Liver Transplantation 2000, 6:415–428.

    Article  PubMed  CAS  Google Scholar 

  65. Broelsch C, Whitington P, Emond J, et al.: Liver transplantation in children from living related donors: surgical techniques and results. Ann Surg 1991, 214:428–437.

    Article  PubMed  CAS  Google Scholar 

  66. Mori K, Nagata I, Yamagata S, et al.: The introduction of microvascular surgery to hepatic artery reconstruction in living-donor liver transplantation: its surgical advantages compared with conventional procedures. Transplantation 1992, 54:263–268.

    Article  PubMed  CAS  Google Scholar 

  67. Egawa H, Uemoto S, Inomata Y, et al.: Biliary complications in pediatric living related liver transplantation. Surgery 1998, 124:901–910.

    PubMed  CAS  Google Scholar 

  68. Emre S, Schwartz M, Shneider B, et al.: Living related liver transplantation for acute liver failure in children. Liver Transpl Surg 1999, 5:161–165. This article describes the clinical experience of a single center using living donor transplantation for fulminant hepatic failure. This approach remains controversial and has not been adopted by many centers.

    Article  PubMed  CAS  Google Scholar 

  69. Miwa S, Hashikura Y, Mita A, et al.: Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure. Hepatology 1999, 30:1521–1526.

    Article  PubMed  CAS  Google Scholar 

  70. Uemoto S, Inomata Y, Sakurai T, et al.: Living donor liver transplantation for fulminant hepatic failure. Transplantation 2000, 70:152–157.

    PubMed  CAS  Google Scholar 

  71. Rosenthal P, Roberts J, Ascher N, Emond J: Auxiliary liver transplant in fulminant failure. Pediatrics 1997, 100:E10.

    Article  PubMed  CAS  Google Scholar 

  72. van Hoek B, de Boer J, Boudjema K, et al.: Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT Study Group. European Auxiliary Liver Transplant Registry. J Hepatol 1999, 30:699–705. This multicenter review of the European experience with auxiliary liver transplantation for fulminant hepatic failure emphasizes the difficulties in predicting the clinical course of fulminant hepatic failure. Analysis of an entire explanted lobe of liver could not be correlated with the ability of the native liver to regenerate. Theoretically, this is the ideal approach for fulminant hepatic failure, although it is technically quite challenging.

    Article  PubMed  Google Scholar 

  73. Whitington P, Emond J, Heffron T, Thistlethwaite J: Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1. Lancet 1993, 342:779–780.

    Article  PubMed  CAS  Google Scholar 

  74. Rela M, Muiesan P, Vilca-Melendez H, et al.: Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I. Ann Surg 1999, 229:565–569.

    Article  PubMed  CAS  Google Scholar 

  75. McDiarmid S, Goss J, Sue P, et al.: One hundred children treated with tacrolimus after primary orthotopic liver transplantation. Transplant Proc 1998, 30:1397–1398.

    Article  PubMed  CAS  Google Scholar 

  76. Stringer M, Marshall M, Muiesan P, et al.: Survival and outcome after hepatic artery thrombosis complicating pediatric liver transplantation. J Pediatr Surg 2001, 36:888–891.

    Article  PubMed  CAS  Google Scholar 

  77. Sakamoto Y, Harihara Y, Nakasuka T, et al.: Rescue of liver grafts from hepatic artery occlussion in living-related liver transplantation. Br J Surg 1999, 86:886–889.

    Article  PubMed  CAS  Google Scholar 

  78. Chardot C, Herrera J, Debray D, et al.: Portal vein complications after liver transplantation for biliary atresia. Liver Transpl Surg 1997, 3:351–358.

    Article  PubMed  CAS  Google Scholar 

  79. Sieders E, Peeters P, ten Vergent E, et al.: Analysis of survival and morbidity after pediatric liver transplantation with full size and technical variant grafts. Transplantation 1999, 68:540–545.

    Article  PubMed  CAS  Google Scholar 

  80. Lopez-Santamarina M, Martinez L, Hierro L: Late biliary complications in pediatric liver transplantation. J Pediatr Surg 1999, 34:316–320.

    Article  Google Scholar 

  81. Lorenz J, Funaki B, Leef J, et al.: Percutaneous transhepatic cholangiography and biliary drainage in pediatric liver transplant patients. Am J Roentgenol 2001, 176:761–765.

    CAS  Google Scholar 

  82. Goss J, Shackleton C, McDiarmid S, et al.: Long term results of pediatric liver transplantation: an analysis of 569 transplants. Ann Surg 1998, 228:411–420.

    Article  PubMed  CAS  Google Scholar 

  83. Reyes J, Jain A, Maqariegos G, et al.: Long-term results after conversion from cyclosporin to tacrolimus in pediatric liver transplantation for acute and chronic rejection. Transplantation 2000, 69:2573–2580.

    Article  PubMed  CAS  Google Scholar 

  84. Gladdy R, Richardson S, Davies H, et al.: Candida infections in pediatric liver transplant recipients. Liver Transpl Surg 1999, 5:16–24.

    Article  PubMed  CAS  Google Scholar 

  85. Green M, Kaufmann M, Wilson J, Reyes J: Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children. Clin Infect Dis 1997, 25:1344–1349. One of the few randomized studies that has involved pediatric liver transplant recipients. The data indicate that long-term antiviral therapy is not necessary for prevention of either cytomegalovirus or Epstein-Barr viral disease.

    PubMed  CAS  Google Scholar 

  86. McDiarmid S, Jordan S, Lee G, et al.: Prevention and preemptive therapy of posttransplant lymphoproliferative disease in pediatric liver recipients. Transplantation 1998, 66:1604–1611. An important approach to the prevention of Epstein-Barr virus-related lymphoproliferative disease is presented.

    Article  PubMed  CAS  Google Scholar 

  87. Kogan D, Burroughs M, Emre S, et al.: Prospective longitudinal analysis of quantitative Epstein-Barr virus polymerase chain reaction in pediatric liver transplant recipients. Transplantation 1999, 67:1068–1070.

    Article  PubMed  CAS  Google Scholar 

  88. Cacciarelli T, Green M, Jaffe R, et al.: Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK 506) therapy. Transplantation 1998, 66:1047–1050.

    Article  PubMed  CAS  Google Scholar 

  89. Kogan D, Burroughs M, Emre S, et al.: The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience. J Pediatr Gastroenterol Nutr 2001, in press.

  90. Smets F, Vajro P, Cornu F, et al.: Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation. Transplantation 2000, 69:982–984.

    Article  PubMed  CAS  Google Scholar 

  91. Reich D, Fiel I, Guarrera J, et al.: Liver transplantation for autoimmune hepatitis. Hepatology 2000, 32:693–700.

    Article  PubMed  CAS  Google Scholar 

  92. Birnbaum A, Benkov K, Pittman N, et al.: Recurrence of autoimmune hepatitis in children after liver transplantation. J Pediatr Gastroenterol Nutr 1997, 25:20–25.

    Article  PubMed  CAS  Google Scholar 

  93. Kerkar N, Hadzic N, Davies E, et al.: De-novo autoimmune hepatitis after liver transplantation. Lancet 1998, 351:409–413. A new entity of posttransplant ‘autoimmune’ hepatitis is described. This entity appears to be distinct from rejection and may require an alternative approach for treatment that relies more on corticosteroids.

    Article  PubMed  CAS  Google Scholar 

  94. Hernandez H, Kovarik P, Whitington P, Alonso E: Autoimmune hepatitis as a late complication of liver transplantation. J Pediatr Gastroenterol Nutr 2001, 32:131–136.

    Article  PubMed  CAS  Google Scholar 

  95. Gupta P, Hart J, Millis J, et al.: De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation 2001, 15:664–668.

    Article  Google Scholar 

  96. Andries S, Casamayou L, Sempoux C, et al.: Pottransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Transplantation 2001, 72:267–272.

    Article  PubMed  CAS  Google Scholar 

  97. Ryckman F, Alonso M, Bucuvalas J, et al.: Long term survival after liver transplantation. J Pediatr Surg 1999, 34:845–850.

    Article  PubMed  CAS  Google Scholar 

  98. Molmenti E, Mazariegos J, Bueno T, et al.: Noncompliance after pediatric liver transplantation. Transplant Proc 1999, 31:408.

    Article  PubMed  CAS  Google Scholar 

  99. Lurie S, Shemesh E, Sheiner P, et al.: Non-adherence in pediatric liver transplant recipients: an assessment of risk factors and natural history. Pediatr Transplant 2000, 4:200–206.

    Article  PubMed  CAS  Google Scholar 

  100. Balistreri W, Bucuvalas J, Ryckman F, et al.: The effect of immunosuppression on growth and development. Liver Transpl Surg 1995, 1:64–73.

    PubMed  CAS  Google Scholar 

  101. Viner R, Forton J, Cole T, et al.: Growth of long term survivors of liver transplantation. Arch Dis Child 1999, 80:235–240.

    Article  PubMed  CAS  Google Scholar 

  102. Bartosh S, Thomas S, Sutton M, et al.: Linear growth after pediatric liver transplantation. J Pediatr 1999, 135:624–631.

    Article  PubMed  CAS  Google Scholar 

  103. McDiarmid S: The necessity for steroid induction or longterm maintenance after liver transplantation: the argument against. Transplant Proc 1998, 30:1449–1451.

    Article  PubMed  CAS  Google Scholar 

  104. Reding R: Steroid withdrawal in liver transplantation. Transplantation 2000, 70:405–410.

    Article  PubMed  CAS  Google Scholar 

  105. Jain A, Mazariegos J, Kashyap R, et al.: Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation. Pediatr Transplant 2001, 5:93015098.

    Article  Google Scholar 

  106. Kennard B, Stewart S, Phelan-McAuliffe D, et al.: Academic outcome in long-term survivors of pediatric liver transplantation. J Dev Behav Pediatr 1999, 20:17–23.

    Article  PubMed  CAS  Google Scholar 

  107. Burroughs M, Moscona A: Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis 2000, 30:857–869.

    Article  PubMed  CAS  Google Scholar 

  108. Dunati M, Zuckerman M, Dhawan A, et al.: Response to varicella immunization in pediatric liver transplant recipients. Transplantation 2000, 70:1401–1404.

    Article  Google Scholar 

  109. Duca P, Del Pont J, D‘Agostino D: Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation. J Pediatr Gastroenterol Nutr 2001, 32:168–170.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pediatrics and Surgery and the Recanati/Miller Transplantation Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1656, 10029, New York, NY, USA

    Debora Kogan-Liberman MD, Sukru Emre MD & Benjamin L. Shneider MD

Authors
  1. Debora Kogan-Liberman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sukru Emre MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Benjamin L. Shneider MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kogan-Liberman, D., Emre, S. & Shneider, B.L. Recent advances in pediatric liver transplantation. Curr Gastroenterol Rep 4, 84–97 (2002). https://doi.org/10.1007/s11894-002-0042-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-002-0042-y

Keywords

Search

Navigation